Page results
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease. It outlines the importance of having your heart checked as part of your care.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
Fiona Farrell works at the Sir William Gowers Unit, a specialist treatment centre for epilepsy and related disorders.
-
This information will give you an overview of BCG immunotherapy, how it is given and side effects it may cause.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
UCLH is continuing to scale up the number of services that offer Advice & Guidance, as well as identifying various improvements within the existing Advice & Guidance service. Over the last few months, UCLH has introduced 5 new specialties to the service, with additional specialties due to go live shortly.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
File results
-
FOI/2022/0764 - Patients treated for drinks spiked/ spiked by needle injection
-
FOI/2022/0768 - Patients treated for Haemophila A
-
FOI/2022/0770 - Parking operations, impact, and parking charge notices issued
-
FOI/2022/0772 - Treatments for rare diseases
-
FOI/2022/0774 - Pre-pregnancy counselling clinics with consultant-led maternity units for women with medical problems
-
FOI/2022/0775 - Data on COVID-19 infections and related illness in staff
-
FOI/2022/0781 - Protocols for diagnosis and treatment of non-small cell lung cancer
-
FOI/2022/0782 - Digital dictation, voice recognition software and outsourced transcription services
-
FOI/2022/0783 - Separate units/ beds allocated for delivery of CAR-T therapy and BMT services
-
FOI/2022/0785 - Patient treatment with Nivolumab